These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 22396741
1. Common variants of the liver fatty acid binding protein gene influence the risk of type 2 diabetes and insulin resistance in Spanish population. Mansego ML, Martínez F, Martínez-Larrad MT, Zabena C, Rojo G, Morcillo S, Soriguer F, Martín-Escudero JC, Serrano-Ríos M, Redon J, Chaves FJ. PLoS One; 2012; 7(3):e31853. PubMed ID: 22396741 [Abstract] [Full Text] [Related]
4. Association between functional FABP2 promoter haplotype and type 2 diabetes. Li Y, Fisher E, Klapper M, Boeing H, Pfeiffer A, Hampe J, Schreiber S, Burwinkel B, Schrezenmeir J, Döring F. Horm Metab Res; 2006 May; 38(5):300-7. PubMed ID: 16718625 [Abstract] [Full Text] [Related]
5. L-FABP T94A is associated with fasting triglycerides and LDL-cholesterol in women. Fisher E, Weikert C, Klapper M, Lindner I, Möhlig M, Spranger J, Boeing H, Schrezenmeir J, Döring F. Mol Genet Metab; 2007 Jul; 91(3):278-84. PubMed ID: 17485234 [Abstract] [Full Text] [Related]
6. Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on insulin resistance and adipocytokines in patients with diabetes mellitus type 2. De Luis DA, Gonzalez Sagrado M, Aller R, Izaola O, Conde R, De la Fuente B. Eur Rev Med Pharmacol Sci; 2010 Feb; 14(2):89-95. PubMed ID: 20329566 [Abstract] [Full Text] [Related]
7. Obesity and Cardiovascular Risk: Variations in Visfatin Gene Can Modify the Obesity Associated Cardiovascular Risk. Results from the Segovia Population Based-Study. Spain. Martínez Larrad MT, Corbatón Anchuelo A, Fernández Pérez C, Pérez Barba M, Lazcano Redondo Y, Serrano Ríos M, Segovia Insulin Resistance Study Group (SIRSG). PLoS One; 2016 Feb; 11(5):e0153976. PubMed ID: 27166797 [Abstract] [Full Text] [Related]
9. Preliminary evidence of FABP2 A54T polymorphism associated with reduced risk of type 2 diabetes and obesity in women from a German cohort. Fisher E, Li Y, Burwinkel B, Kühr V, Hoffmann K, Möhlig M, Spranger J, Pfeiffer A, Boeing H, Schrezenmeir J, Döring F. Horm Metab Res; 2006 May; 38(5):341-5. PubMed ID: 16718632 [Abstract] [Full Text] [Related]
10. Association of variants of the TCF7L2 gene with increases in the risk of type 2 diabetes and the proinsulin:insulin ratio in the Spanish population. González-Sánchez JL, Martínez-Larrad MT, Zabena C, Pérez-Barba M, Serrano-Ríos M. Diabetologia; 2008 Nov; 51(11):1993-7. PubMed ID: 18712344 [Abstract] [Full Text] [Related]
11. The p53 codon 72 (Arg72Pro) polymorphism is associated with the degree of insulin resistance in type 2 diabetic subjects: a cross-sectional study. Bonfigli AR, Sirolla C, Testa R, Cucchi M, Spazzafumo L, Salvioli S, Ceriello A, Olivieri F, Festa R, Procopio AD, Brandoni G, Boemi M, Marra M, Franceschi C. Acta Diabetol; 2013 Jun; 50(3):429-36. PubMed ID: 23269546 [Abstract] [Full Text] [Related]
12. Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on histological alterations and insulin resistance of non alcoholic fatty liver disease. Aller R, De Luis DA, Fernandez L, Calle F, Velayos B, Izaola O, Gonzalez Sagrado M, Conde R, Gonzalez JM. Eur Rev Med Pharmacol Sci; 2009 Jun; 13(5):357-64. PubMed ID: 19961041 [Abstract] [Full Text] [Related]
14. FABP1 Gene Variant is Associated with Risk of Metabolic Syndrome. Zare-Feyzabadi R, Mozaffari M, Ghayour-Mobarhan M, Valizadeh M. Comb Chem High Throughput Screen; 2022 Jun; 25(8):1355-1360. PubMed ID: 34082672 [Abstract] [Full Text] [Related]
15. Polymorphisms in fatty acid binding protein 5 show association with type 2 diabetes. Bu L, Salto LM, De Leon KJ, De Leon M. Diabetes Res Clin Pract; 2011 Apr; 92(1):82-91. PubMed ID: 21288588 [Abstract] [Full Text] [Related]
17. The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study. Lu TM, Lin SJ, Lin MW, Hsu CP, Chung MY. Cardiovasc Diabetol; 2011 Feb 09; 10():16. PubMed ID: 21303562 [Abstract] [Full Text] [Related]
18. Effect of the combination of the variants -75G/A APOA1 and Trp64Arg ADRB3 on the risk of type 2 diabetes (DM2). Morcillo S, Cardona F, Rojo-Martínez G, Almaraz MC, Esteva I, Ruiz-De-Adana MS, Olveira G, García-Fuentes E, Gómez-Zumaquero JM, Soriguer F. Clin Endocrinol (Oxf); 2008 Jan 09; 68(1):102-7. PubMed ID: 17727676 [Abstract] [Full Text] [Related]